154 related articles for article (PubMed ID: 10876238)
1. Pressure-induced local unfolding of the Ras binding domain of RalGDS.
Inoue K; Yamada H; Akasaka K; Herrmann C; Kremer W; Maurer T; Döker R; Kalbitzer HR
Nat Struct Biol; 2000 Jul; 7(7):547-50. PubMed ID: 10876238
[TBL] [Abstract][Full Text] [Related]
2. Structure determination of the Ras-binding domain of the Ral-specific guanine nucleotide exchange factor Rlf.
Esser D; Bauer B; Wolthuis RM; Wittinghofer A; Cool RH; Bayer P
Biochemistry; 1998 Sep; 37(39):13453-62. PubMed ID: 9753431
[TBL] [Abstract][Full Text] [Related]
3. Vibrational Stark effect spectroscopy at the interface of Ras and Rap1A bound to the Ras binding domain of RalGDS reveals an electrostatic mechanism for protein-protein interaction.
Stafford AJ; Ensign DL; Webb LJ
J Phys Chem B; 2010 Nov; 114(46):15331-44. PubMed ID: 20964430
[TBL] [Abstract][Full Text] [Related]
4. A detailed thermodynamic analysis of ras/effector complex interfaces.
Kiel C; Serrano L; Herrmann C
J Mol Biol; 2004 Jul; 340(5):1039-58. PubMed ID: 15236966
[TBL] [Abstract][Full Text] [Related]
5. Ras classical effectors: new tales from in silico complexes.
Fuentes G; Valencia A
Trends Biochem Sci; 2009 Nov; 34(11):533-9. PubMed ID: 19801192
[TBL] [Abstract][Full Text] [Related]
6. Solid-state 31P NMR spectroscopy of precipitated guanine nucleotide-binding protein Ras in complexes with its effector molecules Raf kinase and RalGDS.
Ader C; Spoerner M; Kalbitzer HR; Brunner E
J Phys Chem B; 2007 Mar; 111(10):2752-7. PubMed ID: 17315921
[TBL] [Abstract][Full Text] [Related]
7. Highly fluctuating protein structures revealed by variable-pressure nuclear magnetic resonance.
Akasaka K
Biochemistry; 2003 Sep; 42(37):10875-85. PubMed ID: 12974621
[TBL] [Abstract][Full Text] [Related]
8. Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.
Tsukamoto S; Ihara R; Aizawa A; Kishida S; Kikuchi A; Imai H; Minami N
Biochem Biophys Res Commun; 2006 May; 343(4):1105-12. PubMed ID: 16580637
[TBL] [Abstract][Full Text] [Related]
9. The pressure-temperature free energy-landscape of staphylococcal nuclease monitored by (1)H NMR.
Lassalle MW; Yamada H; Akasaka K
J Mol Biol; 2000 Apr; 298(2):293-302. PubMed ID: 10764598
[TBL] [Abstract][Full Text] [Related]
10. High pressure NMR reveals a variety of fluctuating conformers in beta-lactoglobulin.
Kuwata K; Li H; Yamada H; Batt CA; Goto Y; Akasaka K
J Mol Biol; 2001 Feb; 305(5):1073-83. PubMed ID: 11162115
[TBL] [Abstract][Full Text] [Related]
11. High-pressure NMR study of the complex of a GTPase Rap1A with its effector RalGDS. A conformational switch in RalGDS revealed from non-linear pressure shifts.
Inoue K; Maurer T; Yamada H; Herrmann C; Horn G; Kalbitzer HR; Akasaka K
FEBS Lett; 2001 Oct; 506(3):180-4. PubMed ID: 11602241
[TBL] [Abstract][Full Text] [Related]
12. Identification of Rgl3 as a potential binding partner for Rap-family small G-proteins and profilin II.
Xu J; Shi S; Matsumoto N; Noda M; Kitayama H
Cell Signal; 2007 Jul; 19(7):1575-82. PubMed ID: 17382517
[TBL] [Abstract][Full Text] [Related]
13. Factors determining electrostatic fields in molecular dynamics simulations of the Ras/effector interface.
Ensign DL; Webb LJ
Proteins; 2011 Dec; 79(12):3511-24. PubMed ID: 21748802
[TBL] [Abstract][Full Text] [Related]
14. A residue-level investigation of the equilibrium unfolding of the C2A domain of synaptotagmin 1.
Anbazhagan V; Wang HM; Lu CS; Yu C
Arch Biochem Biophys; 2009 Oct; 490(2):158-62. PubMed ID: 19723500
[TBL] [Abstract][Full Text] [Related]
15. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
[TBL] [Abstract][Full Text] [Related]
16. Volume and free energy of folding for troponin C C-domain: linkage to ion binding and N-domain interaction.
Rocha CB; Suarez MC; Yu A; Ballard L; Sorenson MM; Foguel D; Silva JL
Biochemistry; 2008 Apr; 47(17):5047-58. PubMed ID: 18393534
[TBL] [Abstract][Full Text] [Related]
17. Interaction of a novel GDP exchange inhibitor with the Ras protein.
Ganguly AK; Wang YS; Pramanik BN; Doll RJ; Snow ME; Taveras AG; Remiszewski S; Cesarz D; del Rosario J; Vibulbhan B; Brown JE; Kirschmeier P; Huang EC; Heimark L; Tsarbopoulos A; Girijavallabhan VM; Aust RM; Brown EL; DeLisle DM; Fuhrman SA; Hendrickson TF; Kissinger CR; Love RA; Sisson WA; Webber SE
Biochemistry; 1998 Nov; 37(45):15631-7. PubMed ID: 9843367
[TBL] [Abstract][Full Text] [Related]
18. Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL.
Shirouzu M; Hashimoto K; Kikuchi A; Yokoyama S
Biochemistry; 1999 Apr; 38(16):5103-10. PubMed ID: 10213614
[TBL] [Abstract][Full Text] [Related]
19. RalGDS is required for tumor formation in a model of skin carcinogenesis.
González-García A; Pritchard CA; Paterson HF; Mavria G; Stamp G; Marshall CJ
Cancer Cell; 2005 Mar; 7(3):219-26. PubMed ID: 15766660
[TBL] [Abstract][Full Text] [Related]
20. The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity.
Ryu CH; Kim SW; Lee KH; Lee JY; Kim H; Lee WK; Choi BH; Lim Y; Kim YH; Lee KH; Hwang TK; Jun TY; Rha HK
Oncogene; 2005 Aug; 24(34):5355-64. PubMed ID: 16007223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]